InvestDashboard.com



Valeant Pharmaceuticals International, Inc. (VRX)



$8.31
52 Week Low
$9.25
2017-04-28 15:32:13 MDT
$38.5
52 Week High

Basic Info

Healthcare
Sector
Drug Delivery
Industry
NYSE
Stock Exchange
Canada
Country

Market Cap: $2,990,000,000Mid Cap (Between $2B and $10B)
Analyst Recommendation:3Analysts say: Neutral. (1=Strong Buy, 5=Strong Sell)
Beta: -1.02 Unusual negative beta. Good for diversity? Stock may go up when market goes down, and down when market goes up.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: 15.24%
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: -12.57%
% Above 200 DayMA: -39.70%
VRX Performance 52 Weeks: -75.80%
S&P 500 Performance 52 Weeks: 12.50%
Downtrend is still intact: VRX is below both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
VRX underperforming S&P 500 by -88.30% the last 52 Weeks.

Profile


More Valuation

Price To Book: 0.94
Great Value. Low Price to Book means better value.
EV to EBITDA: 7.98
Great Value! A low EV to EBITDA ratio is great. Ideally, under 10. Under 17 is okay.

More Info

Field Value Average Comments
% Held By Insiders1.96% 17.28%Held by fewer than average Insiders.
% Held By Institutions88.00% 62.07%Institutional percentage greater than average. Institutional buying and selling can really move stock price.
Short % Of Float14.35% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to Equity9.16 1.08 More Aggressive Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %-24.90%-00.18% Profit Margin is less than average.
Operating Margin %12.19%-05.28% Operating Margin greater than average percent. Good.
Return on Equity %-51.86%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %1.59%-01.29% Return on Assets greater than average percent. Good.
Revenue Per Employee $449,767.44 $883,096.70 Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard.
Price to Cash 5.93 5.52 Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Good 5 Yr Est Growth: 15.24%

  2. Price to Book is under 5: 0.94

  3. Better than average EV/EBITDA: 7.98

  4. Operating Margin is positive: 12.19%

  5. Return on Assets is positive: 1.59%

CONS:
  1. Stock is Below Short Term 50DMA: -12.57%

  2. Stock is Below Long Term 200DMA: -39.70%

  3. Stock underperforming S&P 500 over last 52 weeks: -88.30%

  4. Price to Cash Ratio (5.93) is greater than average. Company has less cash as a percent of price than the average.

  5. Shorted more than average: 14.35%

  6. Profit Margin is negative: -24.90%

  7. Return on Equity is negative: -51.86%

  8. Debt To Equity is greater than 2. But might be industry standard? 9.16

  9. Beta is negative. It might be good for diversity, but could also be a warning flag: -1.02


Headlines


Stock Chart


InvestDashboard.com VRX: Valeant Pharmaceuticals International, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.